Actively Recruiting
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
Led by Central Hospital, Nancy, France · Updated on 2024-02-07
1000
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.
CONDITIONS
Official Title
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of Crohn's disease or ulcerative colitis based on clinical, biological, radiological, endoscopic, or histologic criteria
- Weight of at least 45 kilograms
- Affiliated member of the Social Security system
You will not qualify if you...
- Diagnosis of undetermined colitis
- Non-established diagnosis of Crohn's disease
- Women of childbearing age without contraception
- Individuals covered by specific public health code articles (L. 1121-5, L. 1121-7, L1121-8)
- Pregnant or breastfeeding women
- Under 18 years of age
- Persons under legal protection
- Individuals unable to consent
- Persons under 18 deprived of liberty by judicial or administrative decision (articles L. 3212-1 and L. 3213-1)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRU Nancy
Vandœuvre-lès-Nancy, France, 54510
Actively Recruiting
Research Team
A
Adeline GERMAIN, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here